Prognostic Value of Positron Emission Tomography Using F-18-Fluorodeoxyglucose in Patients with Cervical Cancer Undergoing Radiotherapy
- 28 February 2002
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (2) , 289-295
- https://doi.org/10.1006/gyno.2001.6504
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Surgical management of advanced and recurrent cervical cancerSeminars in Surgical Oncology, 1999
- Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d-glucose in Recurrent Colorectal CancerJournal of Clinical Oncology, 1999
- Bromodeoxyuridine Alternating With Radiation for Advanced Uterine Cervix Cancer: A Phase I and Drug Incorporation StudyJournal of Clinical Oncology, 1999
- Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic StudyJournal of Clinical Oncology, 1999
- Radiotherapy for Centrally Recurrent Cervical Cancer of the Vaginal Stump Following HysterectomyGynecologic Oncology, 1997
- Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.Radiology, 1997
- Dynamic MR imaging of recurrent postoperative cervical cancerJournal of Magnetic Resonance Imaging, 1996
- Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.Radiology, 1993
- Routine production of 2-deoxy-2-[18F]fluoro-d-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resinNuclear Medicine and Biology, 1990
- Recurrence of colorectal tumors: PET evaluation.Radiology, 1989